Author Profile
Charles Dhanaraj
Collaborative Commercialization at Gilead Sciences: Resolving the Innovation Vs. Access Tradeoff
Revati Nehru; Nita Sachan; Anand Tatambothla; Professor Charles Dhanaraj
ISB025 | Published June 30, 2013 | 20 pages. Case
Collection: Indian School of Business
The case deals with Gilead Sciences, a bio-pharmaceutical company with several FDA approved HIV/AIDS drugs. In 2006, the company launched the Gilead Access Program to enhance access to HIV/AIDS drugs ... Read More
Organizing for Innovation at Glenmark (A)
Nita Sachan; Professor Charles Dhanaraj
ISB028 | Published June 30, 2013 | 13 pages. Case
Collection: Indian School of Business
The case traces the journey of an Indian pharmaceutical firm, Glenmark Pharmaceuticals, which had traditionally focused on generic drugs, into the area of discovery research. Read More
Organizing for Innovation at Glenmark (B)
Nita Sachan; Professor Charles Dhanaraj
ISB029 | Published June 30, 2013 | 5 pages. Case
Collection: Indian School of Business
The case traces the journey of an Indian pharmaceutical firm, Glenmark Pharmaceuticals, which had traditionally focused on generic drugs, into the area of discovery research. Read More